Analysis of the effectiveness of botulinum toxin type A procurement and access to tiered injections for children with spastic cerebral palsy in Ukraine
DOI:
https://doi.org/10.15574/SP.2025.2(146).5767Keywords:
health care facility, cerebral palsy, spastic form, botulinum toxin type A, botulinum therapy, supply monitoringAbstract
The relevance of the study is determined by global changes in medicine, where an important request is to find effective methods of treatment of pediatric diseases, in particular cerebral palsy (CP), which is the main cause of pediatric disability. According to the World Health Organization, CP is common in 2-5 cases per 1,000 children, and 75% of them have a spastic form, which requires a special approach to treatment. Injections of botulinum toxin type A are one of the most effective methods of reducing spasticity. However, there are problems with access to these drugs in Ukraine, which emphasizes the need to analyze their supply and use in regions.
The aim of the study was to analyze the provision, availability, and use of medicines for the treatment of a spastic form of CP in Kyiv, Zhytomyr, Kharkiv, Dnipro, Zaporizhzhia regions and the city of Kyiv.
Materials and methods. The study covered the monitoring of botulinum toxin type A supply for the period 2019-2023. It consisted of two parts: data were obtained from open databases and official websites, including the Ministry of Health of Ukraine and medical institutions. To assess the drugs prescribed to patients and the level of satisfaction with the supply, surveys and interviews were conducted with patients and healthcare professionals. The survey covered 530 patients with a response rate of over 90%.
Results. The study showed that 40% of respondents complained about the lack of free medicines, and 20% noted their absence in medical facilities. A decrease in delays in supply and problems with treatment interruption were noted by 5% of respondents. Successful public procurement related to the increase in the volume of medicines procured has reduced costs during tenders.
Conclusions. The main factors limiting the provision of medicines for the treatment of children with CP are insufficient funding and an inefficient procurement system in Ukraine.
The authors declare no conflict of interest.
References
Angulo-Parker FJ, Adkinson JM. (2018). Common etiologies of upper extremity spasticity. Hand Clinics. 34(4): 437-442. https://doi.org/10.1016/j.hcl.2018.06.001; PMid:30286958
Bhimani R, Anderson L. (2014). Clinical understanding of spasticity: Implications for practice. Rehabilitation Research and Practice. 2014: 279175. https://doi.org/10.1155/2014/279175; PMid:25276432 PMCid:PMC4168242
Dorf SR, Fonseca AR, Sztajnbok FR, Oliveira TRD, Basttistella LR. (2024). The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: An integrative review. Revista Paulista de Pediatria. 42: e2023093. https://doi.org/10.1590/1984-0462/2024/42/2023093; PMid:38537033 PMCid:PMC10962635
Expert Group on Botulinum Toxin Treatment, Chinese Society of Parkinson's Disease, Movement Disorders. (2018). Chinese expert consensus document on the therapeutic uses of botulinum toxin 2018. Chinese Journal of Neurology. 51(10): 779-786. https://doi.org/10.3760/cma.j.issn.1006-7876.2018.10.002.
Glinac A, Tahirović H, Delalić A. (2013). Family socioeconomic status and health-related quality of life in children with cerebral palsy: Assessing differences between clinical and healthy samples. The Central European Journal of Paediatrics. 9: 183-191. https://doi.org/10.5457/p2005-114.74
Hull M, Anupindi VR, DeKoven M, He J, Bouchard J. (2023). Botulinum toxin utilization, treatment patterns, and healthcare costs among patients with spasticity or cervical dystonia in the US. Advances in Therapy. 40(9): 3986-4003. https://doi.org/10.1007/s12325-023-02563-5; PMid:37414904 PMCid:PMC10427537
Jacinto J, Varriale P, Pain E, Lysandropoulos A, Esquenazi A. (2020). Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in spasticity. Frontiers in Neurology. 11: 388. https://doi.org/10.3389/fneur.2020.00388; PMid:32477251 PMCid:PMC7233119
Kumar D, Kumar R, Mudgal SK, Ranjan P, Kumar S. (2023). The effects of botulinum toxin and casting in spastic children with cerebral palsy: A systematic review and meta-analysis. Cureus. 15(3): e36851. https://doi.org/10.7759/cureus.36851
Ministerstvo okhorony zdorov'ia Ukrainy. (2016). Pro zdiisnennia zakhodiv z kontroliu za vykorystanniam likars'kykh zasobiv ta medychnykh vyrobiv, zakuplenykh za biudzhetni koshty. Nakaz vid 02.06.2016 No. 509. URL: http://www.moz.gov.ua.
Ministerstvo okhorony zdorov'ia Ukrainy. (2019). Pro rozpodil likars'koho zasobu «BOTOKS®» dlia likuvannia ditei, khvorykh na dytiachyi tserebral'nyi paralich, zakuplenoho za koshty Derzhavnoho biudzhetu Ukrainy na 2018 rik za biudzhetnuiu prohramu KPKVK 2301400 «Zabezpechennia medychnykh zakhodiv okremykh derzhavnykh prohram ta kompleksnykh zakhodiv prohramnoho kharakteru». Nakaz vid 08.01.2019 No.26. URL: https://moz.gov.ua/uploads/1/9685-dn_20190108_26_dod.pdf.
Ministerstvo okhorony zdorov'ia Ukrainy. (2019). Pro rozpodil likars'koho zasobu «BOTOKS®» dlia likuvannia ditei, khvorykh na dytiachyi tserebral'nyi paralich, zakuplenoho za koshty Derzhavnoho biudzhetu Ukrainy na 2018 rik. Nakaz vid 09.07.2019 No. 1580. URL: http://www.moz.gov.ua.
Ministerstvo okhorony zdorov'ia Ukrainy. (2018). Pro rozpodil likars'koho zasobu «DYSPORT®» dlia likuvannia ditei, khvorykh na dytiachyi tserebral'nyi paralich, zakuplenoho za koshty Derzhavnoho biudzhetu Ukrainy na 2018 rik. Nakaz vid 09.11.2018 No. 2054. URL: http://www.moz.gov.ua.
Ministerstvo okhorony zdorov'ia Ukrainy. (2019). Pro vnesennya zmin do rozpodilu likarsʹkoho zakhvoryuvannya "DYSPORT" dlya likuvannya ditey, khvorykh na dytyachu tserebralʹnu paralich, zakuplenoho za koshty Derzhavnoho byudzhetu Ukrayiny na 2016 rik, zatverdzhenoho nakazom Ministerstva okhorony zdorov'ya Ukrayiny vid 23 lyutoho 2018 roku No. 334: Nakaz vid 23.07. 2018 No. 1371. URL: http://www.moz.gov.ua.
National Collaborating Centre for Women's and Children's Health (UK). (2012). Spasticity in children and young people with non-progressive brain disorders: Management of spasticity and co-existing motor disorders and their early musculoskeletal complications. London: RCOG Press.
Natsionalna sluzhba zdorovia Ukrainy. (2021). Dopomoha novonarodzhenym ta reabilitatsiyi ditey z tserebralnym paralichem u 2022 rotsi URL: https://nszu.gov.ua/likar-2020.
Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB. (2010). Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: International consensus statement. European Journal of Neurology. 17; Suppl 2: 57-73. https://doi.org/10.1111/j.1468-1331.2010.03128.x; PMid:20633179
Suputtitada A. (2000). Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: Preliminary report. American Journal of Physical Medicine & Rehabilitation. 79(4): 320-326. https://doi.org/10.1097/00002060-200007000-00002; PMid:10892617
World Health Organization. (2020). Children: Improving survival and well-being. URL: https://www.who.int/news-room/fact-sheets/detail/children-reducing-mortality.
World Health Organization. (2023). Disability. URL: https://www.who.int/news-room/fact-sheets/detail/disability-and-health.
Hull M, Danchenko N, Anupindi VR, DeKoven M, He J, Bouchard J, et al. Health care resource utilization and costs among patients with spasticity or cervical dystonia. Journal of Managed Care & Specialty Pharmacy. 30(1): 40: 3986-4003. https://doi.org/10.18553/jmcp.2023.22205; PMid:38055046 PMCid:PMC10775770
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
